MREO

Mereo BioPharma Group PLC

Price

$0.31

return (12m)

-82.24%

p/e

-8.84

p/bv

8.67

DIVIDEND YIELD

0.00%

MREO price

Mereo BioPharma

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment MREO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

3.72%

3 months

-0.13%

1 year

-82.24%

2 years

-92.78%

5 years

-87.83%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals MREO

Valuation

P/E

-8.84

Sector 10.24

Industry 180.72

P/BV

8.67

Sector 1.70

Industry 11.98

P/Revenue (PSR)

Sector 0.84

Industry 12.61

EV/EBITDA

-32.61

Sector 14.60

Industry 390.14

EV/EBIT

-31.22

Sector 19.30

Industry 642.01

P/EBITDA

-9.26

Sector -6.45

Industry 149.66

P/EBIT

-8.86

Sector -5.58

Industry 184.70

P/Total Assets

7.15

Sector 0.69

Industry 6.40

P/Net Current Assets

9.08

Sector -4.21

Industry 0.39

P/Working Capital

8.96

Sector -5.42

Industry 346.02

EPS

-0.03

Sector 0.96

Industry 36.75

BVPS

0.04

Sector 10.49

Industry 154.52

Efficiency

Gross Margin

0.00%

Sector 45.03%

Industry 50.77%

EBITDA Margin

Sector 9.50%

Industry 40.96%

EBIT Margin

Sector 5.13%

Industry 31.00%

Operating Margin

0.00%

Sector 5.25%

Industry 12.08%

Net Profit Margins

0.00%

Sector 2.15%

Industry 17.44%

Asset Turnover

0.00

Sector 0.22

Industry 0.20

Profitability

ROE

-98.07%

Sector 3.97%

Industry 24.52%

ROA

-80.94%

Sector 0.93%

Industry 12.35%

ROIC

-1,013.53%

Sector -15.46%

Industry -

Dividends

Dividend yield

0.00%

Sector 0.30%

Industry 0.93%

Payout

Sector 10.20%

Industry 168.07%

Debt

Current Ratio

5.88

Sector 1.05

Industry 1.36

Net Debt / EBITDA

4.50

Sector 0.24

Industry -6.07

Net Debt / EBIT

4.31

Sector 0.75

Industry -9.99

Net Debt / Equity

-1.05

Sector -0.16

Industry -0.18

Gross Debt / Equity

0.00

Sector 0.16

Industry 0.22

Equity/Assets

0.83

Sector 0.31

Industry 0.53

Liabilities/Assets

0.17

Sector 0.63

Industry 0.85

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals MREO

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
MREO Mereo BioPharma Group PLC	$0.31	-82.14%	0.00%	-8.84	8.67	-98.07%	0.00%
V Visa Inc.	$370.02	7.74%	0.72%	27.40	17.60	64.22%	50.78%
PAYX Paychex Inc.	$115.77	-8.80%	3.92%	23.51	11.08	47.12%	27.03%
BKNG Booking Holdings Inc.	$168.69	-23.22%	0.96%	17.93	-11.99	-66.86%	25.53%
MCO Moody's Corporation	$467.06	-7.94%	0.86%	29.07	25.68	88.34%	34.28%
WM Waste Management Inc.	$211.20	-0.50%	1.68%	29.71	8.54	28.75%	11.12%
ROL Rollins Inc.	$32.91	-40.54%	2.22%	29.79	11.08	37.19%	13.55%
CPRT Copart Inc.	$29.37	-37.01%	0.00%	17.74	3.13	17.66%	33.41%
RHI Robert Half International Inc.	$36.86	15.29%	6.40%	32.09	3.05	9.50%	2.17%
GMAB Genmab A/S	$34.91	24.32%	0.00%	2.52	0.36	14.34%	16.99%
WMG Warner Music Group Corp.	$27.71	-15.00%	2.78%	21.80	15.21	69.78%	9.10%
FLT Fleetcor Technologies Inc.	$0.00	-	0.00%	19.65	5.88	29.91%	26.13%
EFX Equifax Inc.	$160.89	-37.97%	1.36%	27.36	4.33	15.83%	10.80%
TTEK Tetra Tech Inc.	$35.82	-0.01%	0.76%	21.19	4.99	23.56%	8.61%
EXLS ExlService Holdings Inc.	$35.01	-17.76%	0.00%	21.36	6.17	28.86%	11.17%
PKOH Park-Ohio Holdings Corp.	$44.97	110.68%	1.11%	25.83	1.59	6.17%	1.46%
ABM ABM Industries Incorporated	$49.30	12.88%	2.32%	17.36	1.61	9.29%	1.82%
III Information Services Group Inc.	$5.28	2.12%	3.51%	21.70	2.65	12.19%	4.67%
VSEC VSE Corporation	$175.51	5.81%	0.23%	72.32	1.85	2.56%	5.53%
HCSG Healthcare Services Group Inc.	$21.34	37.11%	0.00%	11.93	2.83	23.70%	8.80%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

MREO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Mereo BioPharma

Mereo BioPharma Group PLC

Average Investor10 user rating

4.0 (0 people)

United States

11 years

Founded: 2015

2018

Time since IPO - 8 years

38

Employees

Mereo BioPharma Group PLC (United States) is listed on the Nasdaq and has a market capitalization of $248.30 million, with shareholders equity totaling $28.65 million.

The company employs approximately 38 people and operates in the Services sector, within the Commercial Services industry.

Over the past 12 months, Mereo BioPharma Group PLC reported $- in revenue, generating net income of $-28.10 million.

Key financial metrics include a P/E ratio of -8.84, a price-to-book (P/B) ratio of 8.67, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MREO.

Market cap

$248.30 million

Net worth

$28.65 million

$28,652,000.00

Assets

$34.71 million

$34,714,000.00

Total Shares Outstanding

803.56 million

803,562,000

Average Daily Trading Volume

$4.64 million

$4,641,358.74

Sector

Services

Industry

Commercial Services

MREO

MREO revenue and profits

Financial Results MREO

DRAG THE FRAME TO SEE MORE DATA

MREO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

AMZN - Amazon

$253.57 11,40% (12M)

P/E

20.44

0.00%

ROE

24.52%

P/BV

5.01

WMT - Walmart

$107.50 5,94% (12M)

P/E

38.00

0.91%

ROE

21.53%

P/BV

8.18

COST - Costco Wholesale

$896.33 --5,21% (12M)

P/E

45.02

0.62%

ROE

26.38%

P/BV

11.87

JD - JD.com

$26.91 --20,71% (12M)

P/E

9.86

3.47%

ROE

10.72%

P/BV

1.06

HD - Home Depot

$300.44 --25,68% (12M)

P/E

20.99

3.09%

ROE

85.62%

P/BV

17.97

WBA - Walgreens Boots Alliance

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-83.97%

P/BV

0.00

KR - Kroger

$60.51 --4,09% (12M)

P/E

33.81

2.40%

ROE

18.49%

P/BV

6.25

VZ - Verizon Communications

$47.99 17,90% (12M)

P/E

11.88

5.91%

ROE

15.78%

P/BV

1.87